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Epilepsy is one of the most common chronic neuro-
logic conditions in the world; it affects approximately 
1% of the population17) and in about 30% epilepsy is 
medically intractable1,5,6,12).  The success of epilepsy 
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ABSTRACT
To compare the diagnostic performance of 18F-FDG PET, 11C-FMZ PET, and 11C-FMZ BP imaging 
for the evaluation of patients with intractable partial epilepsy whose MRI findings are normal by 
using statistical imaging analysis.  Ten patients underwent comprehensive presurgical evaluation, 
including PET studies, to assess the epileptic foci.  The extent of cortical resection was based on the 
results of intracranial video-electroencephalography (IVEEG) monitoring and brain mapping under 
stimulation.  The images of 10 patients and 30 controls were spatially normalized to templates 
generated in-house by non-rigid registration and the standardized images of the patients and 
controls were statistically compared.  Epileptic focus candidates were visualized on a color map of 
axial images of each template and the focus site was identified in candidates for lobar location.  In 
patients with Engel I postoperative seizure outcomes we assessed the sensitivity and specificity 
of the imaging methods for lobar focus localization.  We also compared the concordance scores of 
patients with Engel I and Engel II-IV postoperative seizures.  The sensitivity and specificity for 
lobar focus localization on 18F-FDG PET scans was 90.0% and 84.8%, respectively; it was 30.0% 
and 81.4% for 11C-FMZ PET, 40.0% and 66.7% for 11C-FMZ BP images, and 100.0% and 51.4% for 
18F-FDG PET/11C-FMZ PET/11C-FMZ BP images.  In one patient the epileptic focus not detected on 
18F-FDG PET scans was shown on 11C-FMZ BP images.  In patients with Engel I post-treatment 
seizures the concordance scores were significantly higher for 18F-FDG PET than 11C-FMZ PET and 
11C-FMZ BP images (p < 0.05).  With respect to sensitivity and specificity, 18F-FDG PET was 
superior to 11C-FMZ PET and 11C-FMZ BP imaging.  However, in some patients with normal MRI 
results, 11C-FMZ BP studies may complement 18F-FDG PET findings in efforts to identify the 
epileptogenic lobar regions.
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cated, the study population was comprised of 10 
patients who underwent resective surgery guided by 
intracranial video-EEG monitoring (IVEEG).
Evaluation of surgical outcomes
The postoperative outcome was evaluated based on 
the seizure classification of Engel et al4) where class 
I = no disabling seizures, class II = rare disabling 
seizures, class III = improvement, and class IV = 
no improvement.  The postoperative follow-up period 
was at least 1 year.
MRI imaging
For evaluation of the whole brain and hippocam-
pal structures, all patients underwent MRI on a GE 
3T- (GE Medical Systems, Milwaukee, WI, USA) 
and a TOSHIBA 1.5T scanner (Toshiba Medical 
Systems, Otawara, Japan).  The parameters for the 
GE scanner were axial and coronal fluid-attenuated 
inversion recovery (FLAIR) (repetition time/echo 
time [TR/TE] = 10,002/146.3 msec, slice thickness = 
6 mm, field of view [FOV] = 22 cm, matrix = 288 × 
160), axial T2 weighted image (TR/TE = 4,800/99.8 
msec, slice thickness = 6 mm, FOV = 22 cm, matrix 
= 512 × 320), volumetric three-dimensional (3D) T1-
weighted (T1W) images (TR/TE = 5.8/1.9 msec, slice 
thickness = 1.0 mm, FOV = 22 cm, matrix = 320 × 
192).  For the TOSHIBA scanner they were oblique 
axial and coronal FLAIR (TR/TE = 6,200/10.5 
msec, slice thickness = 3 mm, FOV = 22 cm, matrix 
= 320 × 224), oblique axial and coronal T1W images 
acquired by fast spin-echo-based three-dimensional 
real inversion recovery (3D-Real IR) (TR/TE = 
1,800/10.0 msec, slice thickness = 2 mm, FOV = 20 
cm, matrix = 256 × 256).  In all patients these stud-
ies returned normal findings.
MEG recording
MEG recordings were digitized at 600.615 Hz 
using the Neuromag System (whole -head 
306-channel type, Elekta-Neuromag O.Y., Helsin-
ki, Finland).  We simultaneously recorded the 
EEG using 19 scalp electrodes, electrocardio-
grams, and electrooculograms.  MEG recording 
was in 3 - 6 blocks lasting 20 - 30 min with the pa-
tients awake or in spontaneous sleep states.  We 
classified the distribution of an equivalent current 
dipole (ECD) into clusters and scatters9).
PET imaging
18F-FDG PET and 11C-FMZ PET scans of all 10 
patients were performed on a Discovery ST Elite 
PET/CT scanner (GE Medical Systems, Milwau-
kee, WI, USA).  The patients fasted for at least 4 
hr before 18F-FDG PET.  Image acquisition was 
started 50 min after the intravenous (iv) injection of 
18F-FDG (2.8 MBq/kg).  Emission PET data were 
acquired for 7 min in 3D mode after brain CT 
scanning for attenuation correction.  The PET im-
ages were reconstructed using a 3D-ordered subsets 
surgery is partly dependent on the identification of 
the lesions on magnetic resonance images (MRI) 
and patients in whom no lesions are detected by 
MRI have poor surgical outcomes2,22).  At present 
there is no standard for the diagnosis and treatment 
of non-lesional epilepsy.
Functional neuroimaging techniques such as posi-
tron emission tomography (PET) are employed when 
no lesions are seen on MRI scans.  [18F]Fluoro-
2-deoxy-D-glucose PET (18F-FDG-PET) measures 
the glucose metabolism related to the synaptic and 
neuronal activity in brain tissue16); it is commonly 
used in patients scheduled for epilepsy surgery8). 
11C-Flumazenil (11C-FMZ) is a selective GABAA-
benzodiazepine receptor antagonist.  Reduced FMZ 
binding, as is observed in patients with partial epi-
lepsies, is thought to reflect underlying neuronal 
loss.  The binding potential (BP) is the ratio of Bmax, 
the total density of receptors, to KD, the radioligand 
equilibrium-dissociation constant15).  11C-FMZ BP 
is correlated with histologically assessed neuronal 
loss and astrogliosis14).  In patients with frontal lobe 
epilepsy, the cortical focus of decreased FMZ bind-
ing corresponded well with the location of seizure 
onset identified with subdural electrodes; on FDG 
PET images the hypometabolic zone shown on FDG 
PET scans appeared larger than the FMZ focus19). 
There are few reports about the comparison of 18F-
FDG PET, 11C-FMZ PET and 11C-FMZ BP imaging 
among the same patients in localization of the epi-
leptic focus.  As most earlier studies involved pa-
tients with abnormal MRI findings, the relationship 
between 18F-FDG PET and 11C-FMZ PET findings 
with respect to the localization of the epileptic focus 
is less well understood in patients with normal MRI 
findings.
We investigated the diagnostic performance of dif-
ferent PET imaging techniques for the presurgical 
evaluation of patients with non-lesional intractable 
focal epilepsy by subjecting 18F-FDG PET, 11C-FMZ 
PET, and 11C-FMZ BP findings to statistical imag-
ing analysis.
MATERIALS AND METHODS
Patients
We reviewed the clinical records of 16 consecutive 
epilepsy patients seen at the Department of Neuro-
surgery of Hiroshima University Hospital between 
December 2010 and April 2013.  In all, scalp video-
EEG (SVEEG) suggested localization-related epilep-
sy despite normal MRI findings and all underwent 
comprehensive presurgical evaluation including 
SVEEG, magnetoencephalography (MEG), 123I-
iomzenil (IMZ) single-photon emission computed 
tomography (SPECT), PET, and neuropsychological 
examinations.  PET studies were performed at the 
Hiroshima Heiwa Clinic.  As we excluded 6 patients 
because resective surgery, i.e, lobectomy, corticec-
tomy, and amygdalohippocampectomy was not indi-
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were considered registration errors and disregarded. 
The reader selected first and second candidates 
from which registration errors were removed.
Data analysis for localization ability
Lobar concordance was presented if the PET 
localization indicated the same lobar region as 
surgical site.  Lobar concordance was evaluated in 
8 regions (4 cerebral regions of each hemisphere). 
When the results of one or more test of 18F-FDG 
PET, 11C-FMZ PET and 11C-FMZ BP were concor-
dant for the lobar location of the epileptic foci, it was 
defined as concordant in 18F-FDG /11C-FMZ /11C-
FMZ BP.
In patients with postoperative Engel I seizure 
outcome, we assessed the sensitivity and specificity 
of lobar concordance using the first and second can-
didates on 18F-FDG PET, 11C-FMZ PET, 11C-FMZ 
BP image, and 18F-FDG /11C-FMZ /11C-FMZ BP.
Data analysis of the localization in patients with 
postoperative Engel I and Engel II-IV seizures
The localization indicated by the different tests 
was compared based on an earlier study20); the con-
cordance scores were 2 = lobar concordance; 1 = 
hemispheric concordance; 0 = discordance or no lo-
calization.  We assessed the concordance scores by 
using the first candidates in our statistical image 
analysis.  Lobar concordance was presented if the 
PET localization indicated the same lobar region as 
the surgical site, hemispheric concordance if the 
hemisphere was the same.  Otherwise, the findings 
were considered discordant or non-localizing.  The 
total concordance score for each patient was deter-
mined by summing the concordance scores of all 3 
tests.  We compared the concordance scores in pa-
tients with post-treatment Engel I and Engel II-IV 
seizures.  In both groups we used the Shirley-Wil-
liams multiple comparison test to evaluate the con-
cordance scores among F-FDG PET, 11C-FMZ PET, 
and 11C-FMZ BP images.
RESULTS
Seizure profiles
Table 1 shows the clinical profiles, the results of 
presurgical imaging studies, and the resection area 
of the 10 patients, 4 of whom were males.  Their 
ages ranged from 14 to 46 years (mean 28.8 years). 
Five patients had partial seizures alone.  The other 
5 manifested ictal symptoms on SVEEG of partial 
seizures with secondary generalization.  There were 
5 patients with complex partial and one patient 
with simple partial seizures.  The ictal onset on 
SVEEG was localized in 5 patients, 4 had multiple 
foci.  MEG spikes were observed in 8 patients, 3 
had single-cluster ECDs suggestive of the epileptic 
zone.  Two independent clusters were seen in the 
bilateral hemispheres of 2 patients.  In the other pa-
tients there were scattered or no epileptic spikes on 
expectation maximization algorithm in a 128 × 128 
matrix with a FOV of 256 mm × 256 mm and a slice 
thickness of 3.27 mm.
For 11C-FMZ PET, image acquisition was started 
immediately after the iv injection of 11C-FMZ (400 
MBq/body).  Emission PET data were acquired for 
60 min in 3D mode (dynamic acquisition at 40 
sec × 1 frame (Fr), 20 sec × 10 Fr, 60 sec × 4 Fr, 180 
sec × 4 Fr, and 300 sec × 8 Fr).  The PET images 
were reconstructed using a filtered back projection 
algorithm in a 256 × 256 matrix with a FOV of 307 
mm × 307 mm and a slice thickness of 3.27 mm.  We 
produced 11C-FMZ static images and 11C-FMZ BP 
images from 11C-FMZ PET data.  11C-FMZ static 
images were obtained from 40 - 60-min dynamic ac-
quisition data.  11C-FMZ BP images were prepared 
by using a simplified reference tissue model (SRTM) 
that facilitates quantitative receptor imaging with-
out the need for arterial blood samples13).
To obtain data on normal individuals we enlisted 
30 healthy volunteers (15 males, 15 females, age 22 - 
42 years, mean 32.5 years) with normal MRI results 
and no prior history of any medical, developmental, 
or psychiatric disorders; 15 volunteers each under-
went 11C-FMZ PET- and 18F-FDG PET studies.
All 18F-FDG PET, 11C-FMZ PET, and 11C-FMZ 
BP images from the 10 patients and 30 controls 
were spatially normalized to each template, created 
in-house, by non-rigid registration and standardized 
images were obtained.
Statistical image analysis
We compared the standardized images of the 
patients and controls.  Statistical significance was 
set at a Z-score ≦ –2 by voxel-based analysis.  The 
Z-score was obtained with the formula:
The rank order of epileptic focus candidates was 
determined on the basis of the value of R.  R was 
obtained with the formula:
R = the mean Z-score of contiguous voxels with a 
Z-score ≦ –2  × the number of contiguous voxels.  R 
was shown as negative value.
Epileptic focus candidates were visualized on a color 
map on standardized axial 18F-FDG PET, 11C-FMZ 
PET, and 11C-FMZ BP images.
The color map images of epileptic focus candi-
dates were automatically displayed on a computer 
screen.  The candidate regions for epileptic foci were 
colored in 10 steps (e.g.  white = first candidate; 
region with a lowest R value, purple, red, orange 
color, yellow, yellow green, green, sky blue, blue, 
dark blue = region with a highest R value) (See 
colored bar on the left side of Fig. 1A and B).  One 
neuroradiologist with 11 years of experience evalu-
ated the candidate regions on color map images and 
estimated the registration errors.  Candidate re-
gions in cerebrospinal fluid (CSF) or white matter 
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class II-IV).  The residual seizures experienced by 2 
patients (Engel class II) during a one- and two year 
post-operative period abated in the most recent 8 
and 12 months.  In the other 3 (Engel class IV) there 
was no improvement.
Of the 10 patients, 3 had cortical dysplasia and 2 
had gliosis; in one patient it was probably accompa-
nied by cortical dysplasia.  In another patient we 
observed tissue-destructive lesions; the other 4 were 
free of significant alterations.
Localization ability
We selected 5 patients (Cases 1, 2, 3, 4, and 5) 
with good outcomes (Engel class I) to analyze the 
MEG recordings.  In 5 patients 123I-IMZ SPECT 
findings were unilaterally abnormal, in the others 
there were bilateral abnormal or no findings on 123I-
IMZ SPECT.
Surgical procedures, postoperative seizure out-
come, and histological findings
The surgical procedures were single- (n=2) and 
multilobar corticectomy (n=4) and anterior temporal 
lobectomy with amygdalohippocampectomy (n=2) 
or hippocampal transection (n=2) (Table 2).  In the 
course of 20 to 49-month postoperative follow-up 
(mean 35.8 months), 5 patients suffered no (Engel 
class I) and the other 5 residual seizures (Engel 
Table 1. Clinical characteristics of the 10 epilepsy patients
Case Age/Sex Seizure semiology
SVEEG
MEG-ECD
123I-IMZ 
SPECT
18F-FDG PET
11C-FMZ 
PET
11C-FMZ BP
18F-FDG/11C-FMZ/
11C-FMZ BP
Sugical 
resectionictal interictal
1 33/M CPS2nd GTC L F•T L F•T L P cluster L F•T L F•T•P L T•P L T, R T L F•T•P, R T L F•T
2 32/M CPS L T L T R T, L Tscatters L T L F•T L T L T, R T•O L F•T, R T•O L T
3 38/F CPS R F•T R F•T R F•Tcluster R F•T R F, L F L F•O R T•O, L T•O R F•T•O, L F•T•O R F•T
4 22/M CPS2nd GTC R T, L T R T, L T
R T, L T
clusters R T, L T R T•P L T L T R T•P, L T R T
5 14/F SPSCPS Not localized Not localized
R F•T, L F
scatters Not localized R F, L F L F•T R T•O, L T•O R F•T•O, L F•T•O R F
6 46/F CPS R T R T, L T No spike L F•T L F L P R T, L T R T, L F•T•P L T
7 23/F CPS R F, L F R F•T, L F•T R T, L Tclusters Not localized R F, L P R O, L O R T, L T•P R F•T•O, L T•P•O L F
8 28/M CPS2nd GTC R F R F, L F•T R F cluster L T L F L F R T, L T R T, L F•T R F•T
9 28/F
SPS
CPS
2nd GTC
R T•O, L O R T, L T R T•Oscatter R F•O, L F•O R F, L F Not localized R T, L F R F•T, L F R T•O
10 24/F CPS2nd GTC R T, L T R T, L T No spike R T,L T R F•T•P, L F•T•P R F•T, L F R F•T, L P R F•T•P, L F•T•P R T
Abbreviations: CPS = complex partial seizure, 2nd = secondary, GTC = generalized tonic-clonic seizure, SPS = simple partial seizure, SVEEG = scalp video-
electroencephalography, L = left, R = right, F = frontal lobe, T = temporal lobe, O = occipital lobe, P = parietal lobe, MEG = magnetoencephalography, ECD = equivalent 
current dipole, 123I-IMZ SPECT = [123I]iomazenil single-photon emission computed tomography, 18F-FDG PET = [18F]fluoro-2-deoxy-D-glucose positron emission tomography, 
11C-FMZ PET = [11C]flumazenil positron emission tomography, 11C-FMZ BP = [11C]flumazenil binding-potential imaging.
Table 2. Operations and surgical seizure outcomes (Engel class) in 10 patients
Case Age/Sex Operation Engel class Histology
1 33/M L frontal corticectomy, temporal corticectomy I No significant alterations
2 32M L anterior temporal lobectomy with amygdalohippocampectomy I Gliosis and probable focal cortical dysplasia type I
3 38/F R frontal corticectomy, temporal corticectomy I No significant alterations
4 22/M R anterior temporal lobectomy with hippocampal transection I No significant alterations
5 14/F R frontal corticectomy I Cortical dysplasia
6 46/F L anterior temporal lobectomy with hippocampal transection II No significant alterations
7 23/F L frontal corticectomy II Focal cortical dysplasia type IIb
8 28/M R frontal corticectomy, temporal corticectomy IV Gliosis
9 28/F R temporal corticectomy, occipital corticectomy IV Tissue-destructive lesion (etiology unknown)
10 24/F R anterior temporal lobectomy with amygdalohippocampectomy IV Non-hippocampal sclerosis, focal cortical dysplasia type I
Table 3. Results of statistical image analysis of the lobar location of the first and second focus candidates
Case Age/Sex
Imaging technique
Surgical resection
18F-FDG PET 11C-FMZ PET 11C-FMZ BP image 18F-FDG /11C-FMZ /11C-FMZ BP
1 33/M L F•T•P L T•P L T, R T L F•T•P, R T L F•T
2 32/M L F•T L T L T, R T•O L F•T, R T•O L T
3 38/F R F, L F L F•O R T•O, L T•O R F•T•O, L F•T•O R F•T
4 22/M R T•P L T L T R T•P, L T R T
5 14/F R F, L F L F•T R T•O, L T•O R F•T•O, L F•T•O R F
Abbreviations: L = left, R = right, F = frontal lobe, O = occipital lobe, P = parietal lobe, T = temporal lobe, 18F-FDG PET = [18F]fluoro-2-deoxy-D-glucose positron emission 
tomography, 11C-FMZ PET = [11C]flumazenil positron emission tomography, 11C-FMZ BP = [11C]flumazenil binding potential imaging
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diagnostic capability of the various imaging tech-
niques (Table 3).  In patients where first and second 
lobar focus candidates were identified, the sensi-
tivity and specificity for lobar localization were 
greater for 18F-FDG PET than the other imaging 
modalities.  They were 100.0% and 51.4% for 18F-
FDG PET/11C-FMZ PET/11C-FMZ BP imaging 
(Table 4).
In all but Case 3 the epileptic foci were visualized 
on 18F-FDG PET images; they were superior to 11C-
FMZ PET and 11C-FMZ BP images.  In case 3 the 
epileptic focus not visualized on 18F-FDG PET scans 
was revealed on the 11C-FMZ BP image (Fig. 1).
Table 5. Localization concordance among the imaging modalities and the resection site
Case Age/Sex 18F-FDG PET/ score 11C-FMZ PET/ score 11C-FMZ BP image/ score Total score sum Surgical resection Engel class
1 33/M L F•T / 2 L T•P / 2 L T / 2 6 L F•T I
2 32/M L F•T / 2 L T / 2 R T•O / 0 4 L T I
3 38/F R F / 2 L O / 0 L T•O / 0 2 R F•T I
4 22/M R T•P / 2 L T / 0 L T / 0 2 R T I
5 14/F R F / 2 L F / 0 L T•O / 0 2 R F I
6 46/F L F / 1 L P / 1 R T / 0 2 L T II
7 23/F R F / 0 L O / 1 R T / 0 1 L F II
8 28/M L F / 0 L F / 0 L T / 0 0 R F•T IV
9 28/F R F / 1 NA / 0 R T / 2 3 R T•O IV
10 24/F R F•T•P / 2 R F•T / 2 R F•T / 2 6 R T IV
Abbreviations: F = frontal lobe; L = left; NA = not available; O = occipital lobe; P = parietal lobe; R = right; T = temporal lobe
Fig. 1. Case 3. A color map of epileptic focus candidates on each template of axial 18F-FDG PET, and 11C-FMZ 
PET and 11C-FMZ BP images. The patient underwent right frontal and temporal corticectomy based on the 
results of IVEEG monitoring and electrocortical stimulation brain mapping. The reader selected first and 
second candidates from which registration errors were removed. The first and second candidates were used to 
analyze the diagnostic capability (See Table 3).
A: The right frontal lobe was identified as an epileptic focus candidate by 18F-FDG PET but not by 11C-FMZ PET and 11C-FMZ 
BP imaging. The first and second candidates were right frontal lobe (white) and left frontal lobe (purple) on 18F-FDG PET, 
respectively.
B: The right temporal lobe was identified as an epileptic focus candidate by 11C-FMZ BP imaging but not on 18F-FDG PET 
images. The first and second candidates were left temporal and occipital lobe (white) and right temporal and occipital lobe 
(yellow) on 11C-FMZ BP imaging, respectively. Epileptic focus candidates displayed in purple, red and orange color were 
regarded as registration errors.
Table 4. Sensitivity and specificity for lobar focus local-
ization on 18F-FDG PET, 11C-FMZ PET, and 11C-FMZ BP 
images and 18F-FDG /11C-FMZ /11C-FMZ BP in patients 
with Engel I seizure outcomes
Sensitivity Specificity
18F-FDG PET 90.0 % 84.8 %
11C-FMZ PET 30.0 % 81.4 %
11C-FMZ BP image 40.0 % 66.7 %
18F-FDG /11C-FMZ /11C-FMZ BP 100.0 % 51.4 %
A
B
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The sensitivity and specificity for lobar focus lo-
calization on 123I-IMZ SPECT scan were 80.0% and 
97.1%, respectively; they were 30.0% and 81.4% for 
11C-FMZ PET.  We evaluated the images of 123I-
IMZ SPECT visually.  We selected 5 patients (Case 
1, 2, 3, 4, 5) with good outcomes (Engel class I) to 
analyze the diagnostic capability of 123I-IMZ SPECT 
in the same way as PET studies.  123I-IMZ SPECT 
was superior to 11C-FMZ PET for the sensitivity 
especially.  Earlier study demonstrated decreased 
IMZ uptake in ipsilateral mesial temporal region 
in all patients who had mesial temporal epilepsy 
on only one side with normal MRI findings23).
In patient 3, the resection sites were the right 
frontal and temporal lobe.  18F-FDG PET identified 
the right frontal lobe as a candidate for the epileptic 
focus but missed the right temporal lobe; 11C-FMZ 
BP detected this epileptic focus.  This shows that 
11C-FMZ BP studies can complement 18F-FDG PET 
findings in efforts to identify the epileptogenic lobar 
regions in patients with normal MRI results.  Ryv-
lin et al reported that 11C-FMZ PET yielded useful 
information that complemented MRI- and 18F-FDG 
PET findings in specific situations and that in 55% 
of their patients with unilateral cryptogenic frontal 
epilepsy it provided further evidence on the side 
and site of seizure onset18).
The total concordance score tended to be higher 
in patients classified as Engel I than Engel II-IV 
and a high score across the PET studies appeared 
to be associated with favorable surgical outcomes. 
However, possibly due to our small sample size, the 
difference between patients with higher and lower 
scores was not statistically significant.  In our Engel 
I patients the 18F-FDG PET scores were significantly 
higher than the scores of 11C-FMZ PET and 11C-
FMZ BP (p < 0.05).  As we used the seizure-free 
outcome (Engel I) as the reference standard, we 
concluded that 18F-FDG PET was significantly more 
useful than 11C-FMZ PET and 11C-FMZ BP from 
the perspective of the concordance score.
Our study has some limitations.  Our sample size 
was small because we included only epilepsy pa-
tients with normal MRI findings and because we 
excluded patients whose preoperative studies showed 
that local resection was not indicated.  In addition, 
because a seizure-free outcome was our reference 
standard, we included only patients that could be 
followed for at least one year.  Second, a neuroradi-
ologist subjectively identified the first and second 
candidates for epileptic foci on a color map and dis-
counted foci on the CSF or white matter as registra-
tion errors.  A larger database is needed to reduce 
registration errors.
In summary, overall, 18F-FDG PET was superior 
to 11C-FMZ PET and 11C-FMZ BP imaging with re-
spect to sensitivity and specificity.  However, in some 
cases such as our Case 3, 11C-FMZ BP- can comple-
ment 18F-FDG PET findings in efforts to identify 
the epileptogenic lobar regions in patients with 
Focus localization in patients with Engel I and 
Engel II-IV seizure outcomes
Table 5 shows the concordance scores for individ-
ual patients.  Lobar concordance (score=2) on 18F-
FDG PET, 11C-FMZ PET, and 11C-FMZ BP image 
was presented in 6, 3, and 3 patients, respectively. 
The average total concordance score tended to be 
higher in Engel I- than Engel II-IV patients (3.2 vs. 
2.4) but the difference was not statistically signifi-
cant.  Stipulating that the concordance scores of 18F-
FDG PET were higher than those of 11C-FMZ PET 
and 11C-FMZ BP images, multiple comparison tests 
showed that the 18F-FDG PET scores were signifi-
cantly higher (p < 0.05) in Engel I patients; in pa-
tients with persistent seizures (Engel II-IV), the 
difference was not significant.
DISCUSSION
We assessed the sensitivity and specificity for lo-
bar localization of the epileptic focus of different 
imaging modalities in patients whose treatment 
outcome was classified as Engel I.  We found that 
18F-FDG PET was superior to 11C-FMZ PET and 
11C-FMZ BP imaging and that the sensitivity of 18F-
FDG/11C-FMZ/11C-FMZ BP was 100%.  In Case 3, 
11C-FMZ BP did, while 18F-FDG PET did not show 
the epileptic focus, suggesting that the addition of 
11C-FMZ PET increased the sensitivity for detecting 
these foci.  Our reference standard was an Engel I 
seizure outcome after cortical resection rather than 
concordance with IVEEG findings that, because 
they may not localize the epileptogenic zone, repre-
sent a suboptimal reference standard24).
The sensitivity of 18F-FDG PET in patients with 
intractable epilepsy was similar in our and earlier 
studies.  Others7,11,18) reported that its sensitivity 
was 85% - 90% for the detection of epileptic foci in 
patients with temporal lobe epilepsy.  In patients 
with extratemporal epilepsy 18F-FDG PET performs 
more poorly; its sensitivity was 45% - 92% (generally 
~55%) for localizing the epileptic focus in the frontal 
lobe3,10,21).
The sensitivity of 11C-FMZ PET and 11C-FMZ BP 
imaging was lower in our study than in earlier stud-
ies14,18).  The comparison of 18F-FDG PET, 11C-FMZ 
PET and 11C-FMZ BP imaging in epileptic focus 
localization was discussed in very few reports.  In 
addition, most earlier studies involved patients with 
abnormal MRI findings.  This discrepancy between 
our and earlier studies may be attributable to their 
inclusion of patients with abnormal MRI findings. 
In patients with temporal lobe epilepsy, 11C-FMZ BP 
was reduced in all patients with abnormal hippo-
campal volumetry or T2 relaxometry on MRI.  11C-
FMZ BP was reduced in 46% of the patients with a 
hippocampal volume within the normal range14).  In 
100 patients, including 66 patients with abnormal 
MRI findings, 11C-FMZ PET showed abnormality in 
73 % patients18).
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